InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Brennan Nora, Directrice Financière. Director active across 2 companies, notably SPECTRUM PHARMACEUTICALS INC. Aggregated, 7 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €33k. History available since 17 June 2021. The latest transaction was disclosed on 26 May 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
104,823 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:0
463,005 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:1
32,387 shares@ US$1.096100.0% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-025014:0
240,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001064:0
334,507 shares0Common Stock, $0.001 par valueSEC:0001209191-22-039057:0
14,277 shares0Common Stock, $0.001 par valueSEC:0001209191-21-042511
14,277 shares0Common Stock, $0.001 par valueSEC:0001209191-21-042511:0
7 of 7 declarations
About Brennan Nora
Nora Brennan is the EVP and CFO at SPECTRUM PHARMACEUTICALS INC. She is responsible for the company's financial management, including financial planning, risk management, and regulatory compliance. Her expertise in finance is essential to support the growth and profitability of the pharmaceutical company. She plays a key role in developing long-term financial strategies.
